Your activity: 8 p.v.

Society guideline links: Anticoagulation

Society guideline links: Anticoagulation

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

(See "Society guideline links: Atrial fibrillation".)

(See "Society guideline links: Superficial vein thrombosis, deep vein thrombosis, and pulmonary embolism".)

(See "Society guideline links: Antiphospholipid syndrome".)

(See "Society guideline links: Heparin-induced thrombocytopenia (HIT)".)

(See "Society guideline links: Anticoagulation in pregnancy".)

(See "Society guideline links: Thrombotic diseases in infants and children".)

Links to guidelines related to coronavirus disease 2019 (COVID-19) are also provided separately. (See "Society guideline links: COVID-19 – Anticoagulation" and "Society guideline links: COVID-19 – Index of guideline topics".)

International

International Society on Thrombosis and Haemostasis (ISTH): Published guidance

Guidance documents on the periprocedural management of patients on chronic oral anticoagulant therapy – Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk (2019)

Guidance for the management of direct oral anticoagulants in women of childbearing potential (2016)

Guidance on the use of the direct oral anticoagulants in obese patients (2016)

Guidance on when and how to use antidotes for the reversal of direct oral anticoagulants (2016)

Guidance for the management of cancer-associated disseminated intravascular coagulation (2015)

Recommendation on the nomenclature for oral anticoagulants (2015)

Update of the recommendations on biosimilar low-molecular-weight heparins (2013)

Periprocedural antithrombotic and bridging therapy – Recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy (2012)

Recommendation on the selection and assessment of patients treated with the novel oral anticoagulant drugs (2012)

International Council for Standardization in Haematology (ICSH): Recommendations for laboratory measurement of direct oral anticoagulants (2018)

Neurocritical Care Society (NCS) and Society of Critical Care Medicine (SCCM): Guideline for reversal of antithrombotics in intracranial hemorrhage (2015)

Clinical Pharmacogenetics Implementation Consortium (CPIC): Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing (2011)

Canada

Thrombosis Canada (TC): Clinical guides

Choosing Wisely Canada: During interruption of warfarin anticoagulation for procedures, don't 'bridge' with full-dose low molecular weight heparin (LMWH) or unfractionated heparin (UFH) unless the risk of thrombosis is high (2020)

National Advisory Committee on Blood and Blood Products (NAC): Statement on reversal of direct oral anticoagulants (DOACs) (2018)

United States

Anticoagulation Forum (AC Forum): Guidance for reversal of direct oral anticoagulants (2019)

American College of Surgeons (ACS): Guidelines for the perioperative management of antithrombotic medication (2018)

American Society of Hematology (ASH): Guidelines for management of venous thromboembolism – Optimal management of anticoagulation therapy (2018)

Choosing Wisely: Don't routinely use blood products to reverse warfarin (2014)

American College of Chest Physicians (CHEST): Evidence-based clinical practice guidelines for management of anticoagulant therapy – Antithrombotic therapy and prevention of thrombosis, 9th edition (2012)

CHEST: Evidence-based clinical practice guidelines for perioperative management of antithrombotic therapy – Antithrombotic therapy and prevention of thrombosis, 9th edition (2012)

CHEST: Evidence-based clinical practice guidelines on oral anticoagulant therapy – Antithrombotic therapy and prevention of thrombosis, 9th edition (2012)

CHEST: Evidence-based clinical practice guidelines on parenteral anticoagulants – Antithrombotic therapy and prevention of thrombosis, 9th edition (2012)

Europe

European Stroke Organization (ESO): Guideline on reversal of oral anticoagulants in acute intracerebral haemorrhage (2019)

British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE): Guidelines on endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants (2016)

European Society of Anaesthesiology (ESA): Regional anaesthesia and antithrombotic agents – Recommendations (2010)

United Kingdom

British Society of Haematology (BSH): Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis (2020)

BSH: Guideline for the peri-operative management of anticoagulation and antiplatelet therapy (2016)

British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE): Guidelines on endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants (2016)

BSH: Guidance for patient self-testing and self-management of oral anticoagulation with vitamin K antagonists (2014)

BSH: Guidance on the measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis (2014)

BSH: Guidance on the effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban (2012)

BSH: Guideline on the management of bleeding in patients on antithrombotic agents (2012)

BSH: Guidelines on oral anticoagulation with warfarin, 4th edition (2011)

Australia-New Zealand

Royal Australasian College of Physicians (RACP): Low-molecular-weight heparin biosimilars – Potential implications for clinical practice (2014)

Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ): New oral anticoagulants – A practical guide on prescription, laboratory testing and peri-procedural/bleeding management (2014)

Australasian Society and Haemostasis (ASTH): An update of consensus guidelines for warfarin reversal (2013)

Topic 114614 Version 42.0